Sensus Blog

The future of skin cancer treatment is now. Stay ahead of the curve with our library of informational blogs.

November
17
2026

Treating High-Risk NMSC Lesions Without the Scalpel: The Clinical Case for Superficial Radiotherapy

Nearly 900,000 cases of non-melanoma skin cancer are treated via Mohs micrographic surgery each year in the United States. While Mohs surgery remains the gold standard for many cases, advancements in low-energy radiation delivery have…

March
10
2016

Suffering from Unsightly Keloid Scarring? The SRT-100â„¢ is the Perfect Choice for Your Keloid Removal

No more surgery. No more cutting. No more pain. These are just some of the benefits of using the SRT-100â„¢, among others, such as little downtime and no scarring. You may be asking yourself what…

March
10
2016

The SRT-100â„¢ is Revolutionizing Keloid Scar Treatment for Your Patients

Allow us to paint a scenario for you; a patient comes into your practice and seeks keloid treatment after removal. Imagine a process to reduce the chance of a recurrence of his or her scars…

January
19
2016

Give Your Patients Peace of Mind with the SRT-100â„¢ for Basal Cell Carcinoma Treatment

Patients who are diagnosed with basal cell carcinomas have a number of treatment options available. As a physician, you are well aware that most of those options involve surgery of some sort — an unsettling…

January
19
2016

SRT-100â„¢: The Non-Surgical Basal Cell Carcinoma Treatment for Patients Facing Skin Cancer

Basal cell carcinoma is the most frequently occurring form of skin cancer, with more than 2.5 million new cases diagnosed in the U.S. each year. More than one in every three new cancers is skin…

Archives
Archives

IN THE NEWS

Sensus Healthcare Launches Treat Skin Cancer